Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$3.27 - $8.76 $118,792 - $318,233
-36,328 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.24 - $21.25 $36,817 - $63,920
-3,008 Reduced 7.65%
36,328 $518,000
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $10,264 - $16,020
-615 Reduced 1.54%
39,336 $756,000
Q2 2021

Aug 16, 2021

BUY
$18.15 - $27.75 $186,055 - $284,465
10,251 Added 34.52%
39,951 $1.01 Million
Q1 2021

May 14, 2021

BUY
$20.71 - $51.02 $244,378 - $602,036
11,800 Added 65.92%
29,700 $730,000
Q4 2020

Mar 01, 2021

BUY
$21.84 - $44.0 $390,936 - $787,600
17,900 New
17,900 $655,000
Q4 2019

Feb 14, 2020

SELL
$8.73 - $12.95 $1.08 Million - $1.6 Million
-123,499 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$14.16 - $25.34 $44,235 - $79,162
-3,124 Reduced 2.47%
123,499 $1.81 Million
Q2 2019

Aug 15, 2019

BUY
$27.0 - $30.25 $3.42 Million - $3.83 Million
126,623 New
126,623 $0

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $280M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.